BioWorld MedTech

Oct. 15, 2010

Court Report: Medtronic to pay $268M to settle Sprint Fidelis suits

Medtronic (Minneapolis) said Thursday it will pay $268 million to settle U.S. lawsuits related to its Sprint Fidelis family of defibrillation leads which the company recalled three years ago. (Medical Device Daily) Read More

Washington roundup: FDA says it will rescind the controversial Menaflex 510(k)

Report from Europe: PneumRx gets CE mark for RePneu LVRC system

WellDoc, AT&T enter diabetes monitoring software partnership

Financings roundup: World Heart to raise $25.3M in private sale of common stock

MDD's food for med-tech thought

Agreements/contracts: Stöpler set to distribute QuikClot in the Netherlands

Grants roundup: Children's Hospital gets $1M for drug delivery device from NCI

Restructuring roundup: Baxter International creates new medical products business

New ventures: University of Minnesota spins off XO Thermix device startup

People in the News

Product Briefs

Wahlstrom to take over as LifeScience Alley CEO

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...